0000950170-23-040843.txt : 20230809 0000950170-23-040843.hdr.sgml : 20230809 20230809192346 ACCESSION NUMBER: 0000950170-23-040843 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 231156733 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Modig Berndt CENTRAL INDEX KEY: 0001643072 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 1441 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 144 1 primary_doc.xml 144 0001643072 XXXXXXXX LIVE 0001830487 Pharvaris N.V. 001-40010 Emmy Noetherweg 2, 2333 BK Leiden P7 00000 31-(0)71 2036 410 Berndt Modig CEO Ordinary Shares, par value 0.12 per share CS Securities USA LLC
Eleven Madison Avenue New York NY 10010-3623
15000 265650 40822916 08/09/2023 Nasdaq
Ordinary Shares, par value 0.12 per share CS Securities USA LLC
Eleven Madison Avenue New York NY 10010-3623
40000 708400 40822916 08/09/2023 Nasdaq
Ordinary Shares, par value 0.12 per share CS Securities USA LLC
Eleven Madison Avenue New York NY 10010-3623
30000 531300 40822916 08/09/2023 Nasdaq
Ordinary Shares, par value 0.12 per share CS Securities USA LLC
Eleven Madison Avenue New York NY 10010-3623
40000 708400 40822916 08/09/2023 Nasdaq
Ordinary Shares, par value Euro 0.12 per share 01/01/2020 Vested stock options Pharvaris N.V. N 125000 01/01/2020 Services rendered Y 08/09/2023 05/11/2023 /s/ Berndt Modig